Clariant sells Custom Manufacturing Business to International Chemical Investors Group
Clariant's Customer Manufacturing Business supplies a wide range of intermediates and actives ingredients for the agrochemicals, pharmaceuticals and polymers industries. At closing, the new autonomous entity will be one of the world's leading suppliers to the agrochemicals industry with production sites in Germany and the US, according to the company. In 2006, the Custom Manufacturing Business had sales of around CHF 217 million and about 490 employees.
The sales process was initiated only six months ago as a result of the review of the strategic options for the former underperforming Life Science Chemicals Division. Clariant expects to record a book loss of approximately CHF 70 million. The transaction is expected to close by mid-year after fulfilment of local transfer requirements such as approval of all relevant authorities. All assets and personnel will be transferred to the buyer.
Most read news
Topics
Organizations
Other news from the department business & finance
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.